Home > > > > > Report Detail

Anti-Diabetic Pharmaceuticals Market in India 2015

Publisher Name :
Date: 07-Jul-2015
No. of pages: 74

Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world, after China, the market is characterized by a huge demand for anti-diabetic drugs. Huge increase in the number of diabetic patients promotes growth of the anti-diabetics pharmaceutical industry. The incidence of diabetes is higher in developed countries because of unhealthy lifestyles . Development of new and innovative drugs is also providing a boost to the market. Comprehensive health insurance coverage fuels the market growth by raising the affordability among patients. Increasing aging population in India increases the prevalence of diabetes, which in turn gives a boost to the drugs market.

However Price regulation in the insulin market and competition from alternative diabetes treatment hinders the growth of Anti-diabetic pharmaceuticals market in India. In spite of substantial demand-supply gap in the insulin market, foreign manufacturers and importers are facing a huge price challenge. Now-a-days People are becoming more aware of diabetes ,and are trying to move away from unhealthy sedentary lifestyles. Increasing awareness on part of the consumers are making them incorporate more physical exercises and avoid junk food. Such consciousness on part of the consumers is decreasing the growth of diabetes, which is limiting the growth of the anti-diabetic pharmaceutical market to some extent. The Indian Government, on its part, has introduced some diabetes control programmes. Various initiatives taken by the government is providing a boost to this market. The market is expected to exhibit steady growth over the next few years.

Anti-Diabetic Pharmaceuticals Market in India 2015

Table of Contents

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2011-12 - 2014-15), Inflation Rate: Monthly (Dec 2014-Jan 2015 - Mar 2015-Apr 2015)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2014 - Jul 2014), Exchange Rate: Monthly (Dec 2014 - May 2015)
Slide 4: Lending Rate: Annual (2011-12 - 2014-15), Trade Balance: Annual (2011-12 - 2014-15), FDI: Annual (2009-10 - 2013-14)

Introduction
Slide 5: Types of diabetes
Slide 6: Classification of the diabetes market
Slide 7: Classes of anti-diabetic drugs

Market Overview
Slide 8: Global Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth
Slide 9: Indian Anti-Diabetic Pharmaceuticals Market - Overview, Size & Growth
Slide 10: Global Diabetes map

Drivers & Challenges
Slide 11: Summary
Slide 12-15: Key Drivers
Slide 16-17: Key Challenges

Government Initiatives
Slide 18: Government programmes

Market Value Chain
Slide 19: Pharmaceutical Value Chain
Slide 20: Multistage Drug Development Process


Regulation and Patents
Slide 21: Drug regulations
Slide 22-23: Drugs approved for marketing in India
Slide 24: Regulatory Frameworks

Competitive Landscape
Slide 25: Competition Overview
Slide 26: Porter's Five Forces Analysis
Slide 27-31: Competitive benchmarking
Slide 32-71: Major Public Player

Strategic Recommendations
Slide 72: Key Strategic Recommendations

Appendix
Slide 73: Appendix
Slide 74: Sources of information


List of Tables

Regulation and Patents
1. Drugs Approved for Marketing in India

Competitive Landscape
1. Public Trading Comparables (FY 2014) - Top 3 Companies
2. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Key Financial Performance Indicators (All Companies)
e. Key Ratios (All Companies)
f. Business Highlights (All Companies)

Appendix
1. Appendix
2. Sources of Information


List of Figures

Macroeconomic Indicators
1. GDP at Factor Cost: Quarterly (2011-12 - 2014-15)
2. Inflation Rate: Monthly (Dec 2014-Jan 2015 - Mar 2015-Apr 2015)
3. Gross Fiscal Deficit: Monthly (Feb 2014 - Jul 2014)
4. Exchange Rate: Monthly (Dec 2014 - May 2015)
5. Lending Rate: Annual (2011-12, 2012-13, 2013-14, 2014-15)
6. Trade Balance: Annual (2011-12, 2012-13, 2013-14, 2014-15)
7. FDI Annual (2010-11, 2011-12, 2012-13, 2013-14)


Market Overview
1. Global Anti-Diabetic Pharmaceuticals Market - Size & Growth (Value wise) (2013-2018e)
2. People Living with Diabetes (2013)
3. Global Anti-Diabetic Pharmaceuticals Market - Segmentation (2013, 2015e)
4. Indian Anti-Diabetic Pharmaceuticals Market - Size & Growth (Value wise) (2013-2018e)
5. Growth in therapeutic segments (2010)
6. Indian Anti-Diabetic Pharmaceuticals Market - Segmentation (2010, 2015e)


Drivers & Challenges
1. Top 10 countries for number of people with diabetes (20-79 years) (2013)
2. Demography - People >60 years in India (2005, 2010, 2015)
Competitive Landscape
1. Competitive Benchmarking - Key Ratios of Top 3 Companies - Operational Basis (FY 2013)
2. Competitive Benchmarking - Key Ratios of Top 3 Companies - Financial Basis (FY 2013)
3. Company profiles (All Companies)
a. Financial Snapshot (All companies)
b. Key Business Segments (All Companies)
c. Key Geographic Segments (All Companies except for GlaxoSmithKline Pharmaceuticals Ltd.)
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs